Skip to main content

Advertisement

SpringerLink
Log in

Preventative treatment of menstrual migraine

  • Published:
Current Pain and Headache Reports Aims and scope Submit manuscript

Abstract

More than 20 million US women suffer with migraine, two thirds of whom experience menstrually related migraine. Estrogen plays an important role in triggering migraine, and given the numerous hormonal fluctuations throughout a woman’s lifetime, there are many opportunities for a hormonal impact. Accurate diagnosis is key to initiating effective treatment, and when acute therapy fails, the unique predictability of menstrual migraine lends itself to preventative treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Van der Linden JA: De Hemicrania Menstrua. London:1666.

  2. Allais G, Benedetto C: Update on menstrual migraine: from clinical aspects to therapeutical strategies. Neurol Sci 2004, 3:S229–S231.

    Article  Google Scholar 

  3. Epstein MT, Hockaday JM, Hockaday TDR: Migraine and reproductive hormones throughout the menstrual cycle. Lancet 1975, I:543–548.

    Article  Google Scholar 

  4. MacGregor EA: Oestrogen and attacks of migraine with and without aura. Lancet Neurol 2004, 3:354–361.

    Article  PubMed  CAS  Google Scholar 

  5. Coururier EG, Bomhof MA, Neven AK, van Duijn NP: Menstrual migraine in a representative Dutch population sample: prevalence, disability and treatment. Cephalalgia 2003, 23:302–308.

    Article  Google Scholar 

  6. MacGregor EA, Hacjshaw A: Prevalence of migraine on each day of the natural menstrual cycle. Neurology 2004, 3:354–361.

    PubMed  CAS  Google Scholar 

  7. Granella F, Sances G, Allais G, et al.: Characteristics of menstrual and non-menstrual attacks in women with menstrually related migraine referred to headache centers. Cephalalgia 2003, 24:707–716.

    Article  Google Scholar 

  8. Dowson AJ, Kilminster SG, Salt R, et al.: Disability associated with headaches occurring inside and outside the menstrual period in those with migraine: a general practice study. Headache 2005, 45:274–282.

    Article  PubMed  Google Scholar 

  9. Headache Classification Subcommittee of the International Headache Society: The International Classification of Headache Disorders, 2nd edition. Cephalalgia 2004, 24(Suppl 1):9–160.

    Google Scholar 

  10. Silberstein SD, Merriam GR: Sex hormones and headache. J Pain Symptom Manage 1993, 8:243–259.

    Article  Google Scholar 

  11. MacGregor EA: “Menstrual” migraine: towards a definition. Cephalalgia 1996, 16:11–21.

    Article  PubMed  CAS  Google Scholar 

  12. Somerville BW: The role of estradiol withdrawal in the etiology of menstrual migraine. Neurology 1972, 22:355–365.

    PubMed  CAS  Google Scholar 

  13. Somerville BW: Estrogen-withdrawal migraine. Neurology 1975, 25:239–250.

    PubMed  CAS  Google Scholar 

  14. Martin VT: Menstrual migraine: a review of prophylactic therapies. Curr Pain Headache Rep 2004, 8:229–237.

    Article  PubMed  Google Scholar 

  15. Sargent J, Solbach P, Damasio H, et al.: A comparison of naproxen sodium to propranolol hydrochloride and a placebo control for the prophylaxis of migraine headache. Headache 1985, 25:320–324.

    Article  PubMed  CAS  Google Scholar 

  16. Al-Waili NS: Treatment of menstrual migraine with prostaglandin synthesis inhibitor mefenamic acid: double-blind study with placebo. Eur J Med Res 2000, 5:176–182.

    PubMed  CAS  Google Scholar 

  17. Newman LC, Lipton RB, Lay CL, Solomon S: A pilot study of oral sumatriptan as intermittent prophylaxis of menstruation-related migraine. Neurology 1998, 51:307–309.

    PubMed  CAS  Google Scholar 

  18. Newman L, Mannix LK, Landy S, et al.: Naratriptan as short-term prophylaxis of menstrually associated migraine: a randomized, double-blind, placebo-controlled study. Headache 2001, 41:248–256.

    Article  PubMed  CAS  Google Scholar 

  19. Savani N, Loftus J, Mansbachh, Scott A: A randomized, double-blind, placebo-controlled, parallel group evaluation or oral naratriptan 1 mg twice daily as prophylactic treatment for menstrually associated migraine [abstract p-45]. Cephalalgia 2002, 22:25.

    Google Scholar 

  20. Moschiano F, Allais G, Grazzi L, et al.: Naratriptan in the short-term prophylaxis of pure menstrual migraine. Neurol Sci 2005, 26(Suppl 12):S162–S166.

    Article  PubMed  Google Scholar 

  21. Silberstein SD, Elkin AH, Schreiber C, Keywood, C: A randomized trial of frovatriptan for the intermittent prevention of menstrual migraine. Neurology 2004, 63:261–269.

    PubMed  CAS  Google Scholar 

  22. Singer R, Schim J: Frovatriptan for prophylaxis of menstrually associated migraine. Efficacy and tolerability in patients using oral contraceptives compared to nonusers [abstract S168]. Headache 2003, 43:587.

    Google Scholar 

  23. Tuchman M, Hae A, Emeribe U: Oral zolmitriptan 2.5mg demonstrates high efficacy and good tolerability in the prophylactic treatment of menstrual migraine headaches [abstract OR 13]. Headache 2005, 45:771–772.

    Google Scholar 

  24. Edelson RN: Menstrual migraine and other hormonal aspects of migraine. Headache 1985, 25:376–379.

    Article  PubMed  CAS  Google Scholar 

  25. Silberstein SD, Bradley K: DHE-45 in the prophylaxis of menstrually related migraine. Platform presentation at the IX Migraine Trust International Symposium, London, UK. September 1996. Cephalalgia 1996, 16:371.

    Google Scholar 

  26. D’Alessandro R, Gamberini G, Lozito A, Sacquegna T: Menstrual migraine: intermittent prophylaxis with a timedrelease pharmacological formulation of dihydroergotamine. Cephalalgia 1983, 3(Suppl 1):156–158.

    PubMed  Google Scholar 

  27. Facchinetti F, Sances G, Borella P, et al.: Magnesium prophylaxis of menstrual migraine: effects on intracellular magnesium. Headache 1991, 31:298–301.

    Article  PubMed  CAS  Google Scholar 

  28. Silberstein SD: The role of sex hormones in headache. Neurology 1992, 42(Suppl 2):37–42.

    PubMed  CAS  Google Scholar 

  29. Dennerstein L, Morse C, Burrows G, et al.: Menstrual migraine: a double-blind trial of percutaneous estradiol. Gynecol Endocrinol 1988, 2:113–120.

    PubMed  CAS  Google Scholar 

  30. de Lignieres B, Vincens M, Mauvais-Jarvis P, et al.: Prevention of menstrual migraine by percutaneous oestradiol. Br Med J 1986, 293:1540.

    Article  Google Scholar 

  31. Calton GJ, Burnett JW: Danazol and migraine. N Engl J Med 1984, 310:721–722.

    PubMed  CAS  Google Scholar 

  32. O’Dea PK, Davis EH: Tamoxifen in the treatment of menstrual migraine. Neurology 1990, 40:1470–1471.

    PubMed  CAS  Google Scholar 

  33. Herzog AG: Continuous bromocriptine therapy in menstrual migraine. Neurology 1997, 48:101–102.

    PubMed  CAS  Google Scholar 

  34. Holdaway IM, Parr CE, France J: Treatment of a patient with severe menstrual migraine using the depot LHRH analogue Zoladex. Aust N Z J Obstet Gynaecol 1991, 31:164–165.

    PubMed  CAS  Google Scholar 

  35. Murray SC, Muse KN: Effective treatment of severe menstrual migraine headaches with gonadotropin-releasing hormone agonist and “add-back” therapy. Fertil Steril 1997, 67:390–393.

    Article  PubMed  CAS  Google Scholar 

  36. Neri I, Granella F, Nappi R, et al.: Characteristics of headache at menopause: a clinico-epidemiologic study. Maturitas 1993, 17:31–37.

    Article  PubMed  CAS  Google Scholar 

  37. Martin V, Wenke S, Mandell K, et al.: Medical oophorectomy with and without estrogen add-back therapy in the prevention of migraine headache. Headache 2003, 43:309–321.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Headache Institute, St. Luke’s-Roosevelt Hospital Center, 1000 10th Avenue, Suite 1C-10, New York, NY, 10019, USA

    Christine L. Lay MD

Authors
  1. Christine L. Lay MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Susan W. Broner MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christine L. Lay MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lay, C.L., Broner, S.W. Preventative treatment of menstrual migraine. Curr Pain Headache Rep 11, 227–230 (2007). https://doi.org/10.1007/s11916-007-0194-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11916-007-0194-4

Keywords

Search

Navigation